Exceptional increase in somatostatin receptor expression in pancreatic neuroendocrine tumour, visualised with (68)Ga-DOTATOC PET.
Henze
Marcus
M
Clinical Cooperation Unit, Nuclear Medicine, German Cancer Research Center, Heidelberg, Germany. Marcus.Henze@med.uni-heidelberg.de
Schuhmacher
Jochen
J
Dimitrakopoulou-Strauss
Antonia
A
Strauss
Ludwig G
LG
Mäcke
Helmut R
HR
Eisenhut
Michael
M
Haberkorn
Uwe
U
D005710:Gallium Radioisotopes / Q000493:pharmacokinetics; D006801:Humans; D018358:Neuroendocrine Tumors / Q000000981:diagnostic imaging* / Q000378:metabolism*; D015282:Octreotide / Q000031:analogs & derivatives* / Q000493:pharmacokinetics*; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging* / Q000378:metabolism*; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D017481:Receptors, Somatostatin / Q000378:metabolism*
D005710:Gallium Radioisotopes; D019275:Radiopharmaceuticals; D017481:Receptors, Somatostatin; D015282:Octreotide; C106246:Edotreotide